Search Results

Showing results 1 - 10 of 516.
Sort By: Date ▼

Acting DEA administrator announces retirement

June 19, 2018


Robert Patterson, acting administrator of the Drug Enforcement Administration (DEA), in an email sent to DEA staff writes he has "realized that the administrator of the DEA needs to decide and address priorities for years into the future—something which has become increasingly challenging in an acting capacity."

Lawmakers approve dozens of bills to address opioid epidemic

June 18, 2018


The House, which last week considered nearly 40 bills intended to address the opioid epidemic, is scheduled to continue voting on opioid-related legislation this week.

House looks to cut ACA funding in FY 2019 HHS spending bill

June 15, 2018


The House Appropriations Committee's draft fiscal year 2019 spending bill to fund HHS would cut or completely eliminate funding for several health care programs, while increasing funding for others.

How states can use federal Medicaid funds to combat the opioid epidemic, according to CMS

June 13, 2018


Two new CMS documents detail ways states can access federal Medicaid resources to help address the opioid epidemic.

Breaking bones for opioids: Inside the White House's new campaign targeting opioid misuse

June 11, 2018


White House adviser Kellyanne Conway said Trump administration new ads targeting opioid misuse will "communicat[e] directly with the public in a way that will really sharpen the mind to see what is happening with individuals across this country, the extreme length that they will go to" to receive opioids.

CDC: Rate of death by suicide rose 25% from 1999 to 2016

June 11, 2018


CDC Principal Deputy Director Anne Schuchat says, "Suicide is one of the top 10 causes of death in the [United States] right now, and it's one of three causes that is actually increasing recently, so we do consider it a public health problem—and something that is all around us."

Pharma execs knew about OxyContin misuse years before publicly acknowledging it, DOJ report contends

May 31, 2018


A confidential Department of Justice report examined by the New York Times contends that Purdue Pharmaceuticals within the first few years of launching the prescription opioid OxyContin knew about "significant" misuse of the drug, but continued to market the drug as a safer opioid option.
Results Page: [Previous] 1 2 3 4 5  ... [Next]